Brokerages Set Teleflex Incorporated Price Target at $138.50

The medical tech company received a 'Hold' rating from analysts covering the stock.

Apr. 19, 2026 at 9:11am

Got story updates? Submit your updates here. ›

An extreme close-up of a shattered car sensor lens reflecting a faint red light, conceptually illustrating the vandalism of self-driving cars.As tensions over autonomous vehicles escalate, a recent wave of targeted street vandalism exposes pent-up frustration with driverless technology.Wayne Today

Teleflex Incorporated (NYSE:TFX) has received a consensus 'Hold' rating from 10 research firms currently covering the company, with an average 1-year price target of $138.50. The stock has received a mix of ratings, with 2 sell, 5 hold, and 3 buy recommendations.

Why it matters

Teleflex is a diversified medical technology company that designs, manufactures, and distributes devices used in critical care and surgical procedures. Analyst ratings and price targets can provide insight into market sentiment and expectations for the company's performance.

The details

The analysts' ratings and price targets for Teleflex stock are based on the company's financial performance, market position, and growth prospects. The 'Hold' consensus rating suggests analysts see the stock as fairly valued at current levels, with potential upside or downside depending on the company's execution.

  • Teleflex reported Q4 2025 earnings on February 26, 2026.
  • The company paid a quarterly dividend of $0.34 per share on March 31, 2026.

The players

Teleflex Incorporated

A diversified global provider of medical technologies, specializing in critical care and surgery. The company designs, manufactures and distributes devices and solutions used by healthcare professionals.

Royal Bank Of Canada

A research firm that reiterated a 'sector perform' rating on Teleflex shares.

Wall Street Zen

A research firm that downgraded Teleflex from 'hold' to 'sell' rating.

Wells Fargo & Company

A research firm that lifted its target price on Teleflex from $116 to $130 and maintained an 'equal weight' rating.

Raymond James Financial

A research firm that upgraded Teleflex from 'market perform' to 'outperform' and set a $128 target price.

Bank of America

A research firm that upgraded Teleflex from 'underperform' to 'neutral' and set a $135 target price.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.